Parallel liquid-phase synthesis of N-substituted 6-aminosulfonyl-2-oxo-1,2- dihydroquinoline-4-carboxamide and 6-aminosulfonylquinoline-4-carboxamide derivatives

Journal of Combinatorial Chemistry

Volumn 7, Issue 2, 2005, Pages 227-235

  Ivachtchenko, Alexandre V ^a   Kobak, Vladimir V ^a   Ilyn, Alexey P ^a   Khvat, Alexander V ^a   Kysil, Volodymir M ^a   Williams, Caroline T ^a   Kuzovkova, Julia A ^a   Kravchenko, Dmitry V ^a  

^a CHEMDIV INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 AMINOSULFONYL 2 OXO 1,2 DIHYDROQUINOLINE 4 CARBOXAMIDE; 6 AMINOSULFONYLQUINOLINE 4 CARBOXAMIDE; AMIDE; CARBOXYLIC ACID; DIHYDROQUINOLINE DERIVATIVE; ISATIN; MALONIC ACID; QUINOLINE DERIVATIVE; REAGENT; SULFONAMIDE; UNCLASSIFIED DRUG;

ARTICLE; CHLORINATION; LIBRARY; LIQUID; PURIFICATION; REACTION ANALYSIS; SUBSTITUTION REACTION; SYNTHESIS;

COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DESIGN; MOLECULAR STRUCTURE; QUINOLINES; SULFONAMIDES;

EID: 17144364648     PISSN: 15204766     EISSN: None     Source Type: Journal    
DOI: 10.1021/cc049895s     Document Type: Article

References (34)

1. (a) Senkan, S. Angew. Chem., Int. Ed. 2001, 40, 312-329.
2. (b) Hoffmann, R. Angew. Chem., Int. Ed. 2001, 40, 3337-3340.
3. (c) Wess, G.; Urmann, M.; Sickenberger, B. Angew. Chem., Int. Ed. 2001, 40, 3341-3350.
4. (d) Adang, A. E. P.; Hermkens, P. H. H. Curr. Med. Chem. 2001, 8, 985-998.
5. (e) Burgess, H. Curr. Opin. Chem. Biol. 2001, 5, 241-242.
6. An, H.; Dan Cook, P. Chem. Rev. 2000, 100, 3311-3340. Franzen, R. G. J. Comb. Chem. 2000, 2, 195-214.
7. An, H.; Dan Cook, P. Chem. Rev. 2000, 100, 3311-3340. Franzen, R. G. J. Comb. Chem. 2000, 2, 195-214.
8. See, for example: (a) Eastland, G., Jr.; Prous, J.; Castacer, J. Drugs Future 1988, 13, 13. (b) Dejmek, L. Drugs Future 1990, 15, 126. (c) Giardina, G. A.; Raveglia, L. F.; Grugni, M.; Sarau, H. M.; Farina, C.; Medhurst, A. D.; Graziani, D.; Schmidt, D. B.; Rigolio, R.; Luttmann, M.; Cavagnera, S.; Foley, J. J.; Vecchietti, V.; Hay, D. W. J. Med. Chem. 1999, 42, 1053-1065. (d) Suzuki, F.; Nakasato, Y.; Tsumuki, H.; Ohmori, K.; Nakajima, H.; Tamura, T.; Sato, S. U.S. Patent 5371225, 1993; Chem. Abstr. 1994, 120, 217318. (e) Deady, L. W.; Desneves, J.; Kaye, A. J.; Finlay, G. J.; Baguley, B. C.; Denny, W. A. Bioorg. Med. Chem. 2000, 8, 977-984.
9. See, for example: (a) Eastland, G., Jr.; Prous, J.; Castacer, J. Drugs Future 1988, 13, 13. (b) Dejmek, L. Drugs Future 1990, 15, 126. (c) Giardina, G. A.; Raveglia, L. F.; Grugni, M.; Sarau, H. M.; Farina, C.; Medhurst, A. D.; Graziani, D.; Schmidt, D. B.; Rigolio, R.; Luttmann, M.; Cavagnera, S.; Foley, J. J.; Vecchietti, V.; Hay, D. W. J. Med. Chem. 1999, 42, 1053-1065. (d) Suzuki, F.; Nakasato, Y.; Tsumuki, H.; Ohmori, K.; Nakajima, H.; Tamura, T.; Sato, S. U.S. Patent 5371225, 1993; Chem. Abstr. 1994, 120, 217318. (e) Deady, L. W.; Desneves, J.; Kaye, A. J.; Finlay, G. J.; Baguley, B. C.; Denny, W. A. Bioorg. Med. Chem. 2000, 8, 977-984.
10. See, for example: (a) Eastland, G., Jr.; Prous, J.; Castacer, J. Drugs Future 1988, 13, 13. (b) Dejmek, L. Drugs Future 1990, 15, 126. (c) Giardina, G. A.; Raveglia, L. F.; Grugni, M.; Sarau, H. M.; Farina, C.; Medhurst, A. D.; Graziani, D.; Schmidt, D. B.; Rigolio, R.; Luttmann, M.; Cavagnera, S.; Foley, J. J.; Vecchietti, V.; Hay, D. W. J. Med. Chem. 1999, 42, 1053-1065. (d) Suzuki, F.; Nakasato, Y.; Tsumuki, H.; Ohmori, K.; Nakajima, H.; Tamura, T.; Sato, S. U.S. Patent 5371225, 1993; Chem. Abstr. 1994, 120, 217318. (e) Deady, L. W.; Desneves, J.; Kaye, A. J.; Finlay, G. J.; Baguley, B. C.; Denny, W. A. Bioorg. Med. Chem. 2000, 8, 977-984.
11. See, for example: (a) Eastland, G., Jr.; Prous, J.; Castacer, J. Drugs Future 1988, 13, 13. (b) Dejmek, L. Drugs Future 1990, 15, 126. (c) Giardina, G. A.; Raveglia, L. F.; Grugni, M.; Sarau, H. M.; Farina, C.; Medhurst, A. D.; Graziani, D.; Schmidt, D. B.; Rigolio, R.; Luttmann, M.; Cavagnera, S.; Foley, J. J.; Vecchietti, V.; Hay, D. W. J. Med. Chem. 1999, 42, 1053-1065. (d) Suzuki, F.; Nakasato, Y.; Tsumuki, H.; Ohmori, K.; Nakajima, H.; Tamura, T.; Sato, S. U.S. Patent 5371225, 1993; Chem. Abstr. 1994, 120, 217318. (e) Deady, L. W.; Desneves, J.; Kaye, A. J.; Finlay, G. J.; Baguley, B. C.; Denny, W. A. Bioorg. Med. Chem. 2000, 8, 977-984.
12. See, for example: (a) Eastland, G., Jr.; Prous, J.; Castacer, J. Drugs Future 1988, 13, 13. (b) Dejmek, L. Drugs Future 1990, 15, 126. (c) Giardina, G. A.; Raveglia, L. F.; Grugni, M.; Sarau, H. M.; Farina, C.; Medhurst, A. D.; Graziani, D.; Schmidt, D. B.; Rigolio, R.; Luttmann, M.; Cavagnera, S.; Foley, J. J.; Vecchietti, V.; Hay, D. W. J. Med. Chem. 1999, 42, 1053-1065. (d) Suzuki, F.; Nakasato, Y.; Tsumuki, H.; Ohmori, K.; Nakajima, H.; Tamura, T.; Sato, S. U.S. Patent 5371225, 1993; Chem. Abstr. 1994, 120, 217318. (e) Deady, L. W.; Desneves, J.; Kaye, A. J.; Finlay, G. J.; Baguley, B. C.; Denny, W. A. Bioorg. Med. Chem. 2000, 8, 977-984.
13. Farina, C.; Gagliardi, S.; Giardina, G.; Grugni, M.; Martinelli, M.; Nadler, G. WO 0238547, 2002. Der. Abst. C 2002, 454769.
14. Suzuki, F.; Hayashi, H.; Miwa, Y.; Ishii, A.; Ichikawa, S.; Miki, I. EP 0458636, 1995. Chem. Abstr. 1996, 15, 202043f.
15. (a) Li, J.-H.; Kalish, V. J.; Zhang, J.; Serdyuk, L. E.; Ferraris, D. V.; Xiao, G.; Kletzly, P. W. WO 0190077, 2001.
16. (b) Desos, P.; Ruano, E.; Al-Badri, H.; Fugier, C.; Chapman, A. G.; Meldrum, B. S.; Thomas, J.-Y.; Roger, A.; Lestage, P.; Cordi, A. A. Drugs Future 2002, 27 (Suppl. A), P212.
17. For some recent examples of small-molecule preclinical and clinical candidates containing the heteroarylsulfonamide moiety, see: (a) Maignan, S.; Guilloteau, J. P.; Pouzieux, S.; Choi-Sledeski, Y. M.; Becker, M. R.; Klein, S. I.; Ewing, W. R.; Pauls, H. W.; Spada, A. P.; Mikol, V. J. Med. Chem. 2000, 43, 3226-3232. (b) Owa, T.; Yoshino, H.; Okauchi, T.; Okabe, T.; Ozawa, Y.; Hata Sugi, N.; Yoshimatsu, K.; Nagasu, T.; Koyanagi, N.; Kitoh, K. Bioorg. Med. Chem. Lett. 2002, 12, 2097-2100. (c) Barlaam, B.; Bird, T. G.; Lambert-van der Brempt, C.; Campbell, D.; Foster, S. J.; Maciewicz, R. J. Med. Chem. 1999, 42, 4890-4908. (d) Dieterle, W.; Mann, J.; Kutz, K. J. Clin. Pharmacol. 2004, 44, 59-66. (e) Deng, L.; Chen, G. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 13025-13029. (f) Borras, J.; Scozzafava, A.; Menabuoni, L.; Muncione, F.; Briganti, F.; Mincione, G.; Supuran, C. T. Bioorg. Med. Chem. 1999, 7, 2397-2406.
18. For some recent examples of small-molecule preclinical and clinical candidates containing the heteroarylsulfonamide moiety, see: (a) Maignan, S.; Guilloteau, J. P.; Pouzieux, S.; Choi-Sledeski, Y. M.; Becker, M. R.; Klein, S. I.; Ewing, W. R.; Pauls, H. W.; Spada, A. P.; Mikol, V. J. Med. Chem. 2000, 43, 3226-3232. (b) Owa, T.; Yoshino, H.; Okauchi, T.; Okabe, T.; Ozawa, Y.; Hata Sugi, N.; Yoshimatsu, K.; Nagasu, T.; Koyanagi, N.; Kitoh, K. Bioorg. Med. Chem. Lett. 2002, 12, 2097-2100. (c) Barlaam, B.; Bird, T. G.; Lambert-van der Brempt, C.; Campbell, D.; Foster, S. J.; Maciewicz, R. J. Med. Chem. 1999, 42, 4890-4908. (d) Dieterle, W.; Mann, J.; Kutz, K. J. Clin. Pharmacol. 2004, 44, 59-66. (e) Deng, L.; Chen, G. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 13025-13029. (f) Borras, J.; Scozzafava, A.; Menabuoni, L.; Muncione, F.; Briganti, F.; Mincione, G.; Supuran, C. T. Bioorg. Med. Chem. 1999, 7, 2397-2406.
19. For some recent examples of small-molecule preclinical and clinical candidates containing the heteroarylsulfonamide moiety, see: (a) Maignan, S.; Guilloteau, J. P.; Pouzieux, S.; Choi-Sledeski, Y. M.; Becker, M. R.; Klein, S. I.; Ewing, W. R.; Pauls, H. W.; Spada, A. P.; Mikol, V. J. Med. Chem. 2000, 43, 3226-3232. (b) Owa, T.; Yoshino, H.; Okauchi, T.; Okabe, T.; Ozawa, Y.; Hata Sugi, N.; Yoshimatsu, K.; Nagasu, T.; Koyanagi, N.; Kitoh, K. Bioorg. Med. Chem. Lett. 2002, 12, 2097-2100. (c) Barlaam, B.; Bird, T. G.; Lambert-van der Brempt, C.; Campbell, D.; Foster, S. J.; Maciewicz, R. J. Med. Chem. 1999, 42, 4890-4908. (d) Dieterle, W.; Mann, J.; Kutz, K. J. Clin. Pharmacol. 2004, 44, 59-66. (e) Deng, L.; Chen, G. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 13025-13029. (f) Borras, J.; Scozzafava, A.; Menabuoni, L.; Muncione, F.; Briganti, F.; Mincione, G.; Supuran, C. T. Bioorg. Med. Chem. 1999, 7, 2397-2406.
20. For some recent examples of small-molecule preclinical and clinical candidates containing the heteroarylsulfonamide moiety, see: (a) Maignan, S.; Guilloteau, J. P.; Pouzieux, S.; Choi-Sledeski, Y. M.; Becker, M. R.; Klein, S. I.; Ewing, W. R.; Pauls, H. W.; Spada, A. P.; Mikol, V. J. Med. Chem. 2000, 43, 3226-3232. (b) Owa, T.; Yoshino, H.; Okauchi, T.; Okabe, T.; Ozawa, Y.; Hata Sugi, N.; Yoshimatsu, K.; Nagasu, T.; Koyanagi, N.; Kitoh, K. Bioorg. Med. Chem. Lett. 2002, 12, 2097-2100. (c) Barlaam, B.; Bird, T. G.; Lambert-van der Brempt, C.; Campbell, D.; Foster, S. J.; Maciewicz, R. J. Med. Chem. 1999, 42, 4890-4908. (d) Dieterle, W.; Mann, J.; Kutz, K. J. Clin. Pharmacol. 2004, 44, 59-66. (e) Deng, L.; Chen, G. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 13025-13029. (f) Borras, J.; Scozzafava, A.; Menabuoni, L.; Muncione, F.; Briganti, F.; Mincione, G.; Supuran, C. T. Bioorg. Med. Chem. 1999, 7, 2397-2406.
21. For some recent examples of small-molecule preclinical and clinical candidates containing the heteroarylsulfonamide moiety, see: (a) Maignan, S.; Guilloteau, J. P.; Pouzieux, S.; Choi-Sledeski, Y. M.; Becker, M. R.; Klein, S. I.; Ewing, W. R.; Pauls, H. W.; Spada, A. P.; Mikol, V. J. Med. Chem. 2000, 43, 3226-3232. (b) Owa, T.; Yoshino, H.; Okauchi, T.; Okabe, T.; Ozawa, Y.; Hata Sugi, N.; Yoshimatsu, K.; Nagasu, T.; Koyanagi, N.; Kitoh, K. Bioorg. Med. Chem. Lett. 2002, 12, 2097-2100. (c) Barlaam, B.; Bird, T. G.; Lambert-van der Brempt, C.; Campbell, D.; Foster, S. J.; Maciewicz, R. J. Med. Chem. 1999, 42, 4890-4908. (d) Dieterle, W.; Mann, J.; Kutz, K. J. Clin. Pharmacol. 2004, 44, 59-66. (e) Deng, L.; Chen, G. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 13025-13029. (f) Borras, J.; Scozzafava, A.; Menabuoni, L.; Muncione, F.; Briganti, F.; Mincione, G.; Supuran, C. T. Bioorg. Med. Chem. 1999, 7, 2397-2406.
22. For some recent examples of small-molecule preclinical and clinical candidates containing the heteroarylsulfonamide moiety, see: (a) Maignan, S.; Guilloteau, J. P.; Pouzieux, S.; Choi-Sledeski, Y. M.; Becker, M. R.; Klein, S. I.; Ewing, W. R.; Pauls, H. W.; Spada, A. P.; Mikol, V. J. Med. Chem. 2000, 43, 3226-3232. (b) Owa, T.; Yoshino, H.; Okauchi, T.; Okabe, T.; Ozawa, Y.; Hata Sugi, N.; Yoshimatsu, K.; Nagasu, T.; Koyanagi, N.; Kitoh, K. Bioorg. Med. Chem. Lett. 2002, 12, 2097-2100. (c) Barlaam, B.; Bird, T. G.; Lambert-van der Brempt, C.; Campbell, D.; Foster, S. J.; Maciewicz, R. J. Med. Chem. 1999, 42, 4890-4908. (d) Dieterle, W.; Mann, J.; Kutz, K. J. Clin. Pharmacol. 2004, 44, 59-66. (e) Deng, L.; Chen, G. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 13025-13029. (f) Borras, J.; Scozzafava, A.; Menabuoni, L.; Muncione, F.; Briganti, F.; Mincione, G.; Supuran, C. T. Bioorg. Med. Chem. 1999, 7, 2397-2406.
23. Pfitzinger, W. J. Prakt. Chem. 1886, 33, 100.
24. For example: (a) Scipchandler, M. T.; Mattingly, P. G. Heterocydes 1990, 31, 555-561. (b) Morales-Rios, M. S.; Martinez-Galero, M. L.-C.; Joseph-Nathan, P. J. Org. Chem. 1995, 60, 6194-6197. (c) Chen, S. F.; Papp, L. M.; Ardecky, R. J.; Rao, G. V.; Hesson, D. P.; Forbes, M.; Dexter, D. L. Biochem. Pharmacol. 1990, 40, 709-714. (d) Lackey, K.; Sternbach, D. D. Synthesis 1993, 10, 993-997.
25. For example: (a) Scipchandler, M. T.; Mattingly, P. G. Heterocydes 1990, 31, 555-561. (b) Morales-Rios, M. S.; Martinez-Galero, M. L.-C.; Joseph-Nathan, P. J. Org. Chem. 1995, 60, 6194-6197. (c) Chen, S. F.; Papp, L. M.; Ardecky, R. J.; Rao, G. V.; Hesson, D. P.; Forbes, M.; Dexter, D. L. Biochem. Pharmacol. 1990, 40, 709-714. (d) Lackey, K.; Sternbach, D. D. Synthesis 1993, 10, 993-997.
26. For example: (a) Scipchandler, M. T.; Mattingly, P. G. Heterocydes 1990, 31, 555-561. (b) Morales-Rios, M. S.; Martinez-Galero, M. L.-C.; Joseph-Nathan, P. J. Org. Chem. 1995, 60, 6194-6197. (c) Chen, S. F.; Papp, L. M.; Ardecky, R. J.; Rao, G. V.; Hesson, D. P.; Forbes, M.; Dexter, D. L. Biochem. Pharmacol. 1990, 40, 709-714. (d) Lackey, K.; Sternbach, D. D. Synthesis 1993, 10, 993-997.
27. For example: (a) Scipchandler, M. T.; Mattingly, P. G. Heterocydes 1990, 31, 555-561. (b) Morales-Rios, M. S.; Martinez-Galero, M. L.-C.; Joseph-Nathan, P. J. Org. Chem. 1995, 60, 6194-6197. (c) Chen, S. F.; Papp, L. M.; Ardecky, R. J.; Rao, G. V.; Hesson, D. P.; Forbes, M.; Dexter, D. L. Biochem. Pharmacol. 1990, 40, 709-714. (d) Lackey, K.; Sternbach, D. D. Synthesis 1993, 10, 993-997.
28. Ivachtchenko, A. V.; Kobak, V. V.; Ilyin, A. P.; Trifilenkov, A. S.; Busel, A. A. J. Comb. Chem. 2003, 5, 645-652.
29. Ivachtchenko, A. V.; Il'yin, A. P.; Kobak, V. V.; Zolotarev, D. A.; Boksha, L. V.; Trifilenkov, A. S.; Ugoleva, D. M. J. Comb. Chem. 2002, 4, 419-428.
30. Ivachtchenko, A. V.; Kobak, V. V.; Khvat, A. V.; Williams, C. T. Presented at the 19th International Congress of Heterocyclic Chemistry, Fort Collins, CO, August 10-15, 2003; Abstract: 12-PO-105, 205.
31. Radul, O. M.; Bukhanyuk, S. M.; Rekhter, M. A.; Zhungietu, G. I.; Ivanova, I. P. Khim. Geterotsikl. Soedin. 1982, 18, 1427-1430.
32. Ivachtchenko, A. V.; Khvat, A. V.; Kobak, V. V.; Kysil, V. M.; Williams, C. T. Tetrahedron Lett. 2004, 45, 5473-5476.
33. Baru, M.; Ivachtchenko, A. Russian Patent 2,180,609, 2002; Patent PCT WO 02/087740 A1, 2002; Chem. Abstr. 2003, 138, 014907f.
34. For a description of this equipment, see: Technology Platform. In Custom Chemistry; Chemical Diversity Labs, Inc.: San Diego, CA, 2002; p 5. Available at http://www.chemdiv.com.